President Trump is set to unveil a new policy aimed at reducing prescription drug expenses, with a focus on expanding access to international pricing models for Medicaid programs nationwide. The initiative would allow all states to adopt "most favored nation" pricing for select medications, potentially lowering costs for beneficiaries. Health and Human Services Secretary Robert F. Kennedy Jr. will participate in the announcement, signaling a high-level push to reshape drug affordability. Critics and supporters alike will likely scrutinize whether this approach could set a precedent for broader pharmaceutical pricing reforms.
President Trump will deliver remarks Friday on another step in his administration’s efforts to lower prescription drug costs. Trump is expected to announce that Medicaid programs in all 50 states will have access to “most favored nation” pricing for certain drugs. He will be joined by Health and Human Services Secretary Robert F. Kennedy Jr.,...
